These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15235931)

  • 61. The effect of exercise during haemodialysis on solute removal.
    Kong CH; Tattersall JE; Greenwood RN; Farrington K
    Nephrol Dial Transplant; 1999 Dec; 14(12):2927-31. PubMed ID: 10570099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparisons of Kt/V evaluated using an online method and calculated from urea measurements in patients on intermittent hemodialysis.
    Grzegorzewska AE; Banachowicz W
    Hemodial Int; 2006 Oct; 10 Suppl 2():S5-9. PubMed ID: 17022752
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis.
    Schneditz D; Platzer D; Daugirdas JT
    Nephrol Dial Transplant; 2009 Jul; 24(7):2218-24. PubMed ID: 19211646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving the efficiency of short-term single-needle hemodialysis.
    Rostoker G; Griuncelli M; Loridon C; Bourlet T; Welsch K; Benmaadi A
    Ren Fail; 2009; 31(4):261-6. PubMed ID: 19462273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
    Kaczmarczyk I; Kraśniak A; Drozdz M; Chowaniec E; Gajda M; Radziszewski A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adequacy of hemodialysis in Nepalese patients undergoing maintenance hemodialysis.
    Sultania P; Acharya PS; Sharma SK
    JNMA J Nepal Med Assoc; 2009; 48(173):10-3. PubMed ID: 19529051
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What is a surrogate marker for optimal dialysis?
    Ishizaki M; Matsunaga T; Itagaki I
    Hemodial Int; 2007 Oct; 11(4):478-84. PubMed ID: 17922747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
    Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
    Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blood pump speed vs. actual or "compensated" blood flow rate.
    Williams HF; Jensen K; Gillum D; Nabut J
    Nephrol Nurs J; 2007; 34(5):491-9, 525. PubMed ID: 18041451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
    Salimi J; Razeghi E; Karjalian H; Meysamie A; Dahhaz M; Dadmehr M
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):781-4. PubMed ID: 18711295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of body mass index with decline in residual kidney function after initiation of dialysis.
    Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
    Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Formal analytical solution to a regional blood flow and diffusion based urea kinetic model.
    Schneditz D; Daugirdas JT
    ASAIO J; 1994; 40(3):M667-73. PubMed ID: 8555598
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Individual dialysis using computer-controlled prescription].
    Kovarik J; Graf H; Irschik H; Pohanka E; Stummvoll HK
    Wien Klin Wochenschr; 1985 Nov; 97(21):809-12. PubMed ID: 3904224
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of urea nitrogen and creatinine kinetics in hemodialysis: comparison of a variable-volume two-compartment model with a regional blood flow model and investigation of an appropriate solute kinetics model for clinical application.
    Yamada T; Hiraga S; Akiba T; Marumo F
    Blood Purif; 2000; 18(1):18-29. PubMed ID: 10686439
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phosphate end dialysis value: a misleading parameter of hemodialysis efficiency. French Society for Pediatric Nephrology.
    Fischbach M; Boudailliez B; Foulard M
    Pediatr Nephrol; 1997 Apr; 11(2):193-5. PubMed ID: 9090662
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High vitreous urea rebound in a glaucoma patient with increased intraocular pressure during hemodialysis.
    Ghaffariyeh A; Honarpisheh N; Pishva E
    Can J Ophthalmol; 2009 Oct; 44(5):e51. PubMed ID: 19798819
    [No Abstract]   [Full Text] [Related]  

  • 79. Post-dialysis urea rebound.
    Hassaballah AM; Ayadi A; Shaheen MH; Barsoum RS; el-Badry A
    J Egypt Med Assoc; 1974; 57(5-6):215-26. PubMed ID: 4452764
    [No Abstract]   [Full Text] [Related]  

  • 80. Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound.
    Smye SW; Evans JH; Will E; Brocklebank JT
    Clin Phys Physiol Meas; 1992 Feb; 13(1):51-62. PubMed ID: 1563221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.